Elmiron (Pentosan Polysulfate, or PPS) is manufactured by Janssen Pharmaceuticals. It is the only FDA-approved drug used to treat interstitial cystitis. This incurable condition affects more than 200,000 people per year, with women being four times more likely than men to experience its symptoms. Though Elmiron's exact mechanism is not fully understood, it has been found to provide relief when taken continuously.
Elmiron has been on the market for over twenty years. However, in the Spring of 2018, researchers from the Emory Eye Center submitted a letter to the editor of the Journal of Urology, notifying them of "vision-threatening retinal changes associated with long-term exposure to PPS." Those changes followed the use of standard dosages of the medication raging from 200 to 400 mgs per day for a median of 15.5 years, with greater usage of the medication being directly linked to more extensive damage to the eye.
Patients who have experienced difficulty reading, vision loss, or difficulty seeing in dimmed or lower lights after having been prescribed Elmiron may be eligible to file a lawsuit against Janssen Pharmaceuticals. To qualify to file a lawsuit, you must meet the following criteria:
Elmiron has also been reported to cause several other side effects, including:
Filing an Elmiron lawsuit could lead to receiving compensation for medical expenses, lost wages, pain and suffering and additional economic and non-economic injuries that you suffered as a result of the use of Elmliron.
Contact us and we'll provide you with a no-cost evaluation of the compensation you could receive. Our review is completely free, and if we represent you and you are compensated you'll pay no out-of-pocket costs at all.
Our experienced team will evaluate your claim and help you maximize the amount of money you receive. Time is limited. Act now to receive compensation.